Drug Topics - May 12, 2008 - (Page 56) 56 DRUG TOPICS MAY 12, 2008 www.drugtopics.com Self-Care Probiotics are all the rage: How you can capitalize on it Sandra Levy hen Kelly Karpa’s two-year-old son was diagnosed with Clostridium difficile diarrhea in 2001, and his symptoms didn’t disappear after antibiotic therapy, Karpa took him to Johns Hopkins University. There he was treated by a physician who had experience with probiotics. For 10 days Karpa’s son was given six grams of bacteria as well as vancomycin, one of the prescriptions he had already been taking. “For the first time in 10 months, when we stopped the vancomycin, the symptoms did not return. That was my wake-up call. As a healthcare professional, I had until then gone by the mantra of ‘Stay away from these natural products because they are not good,’” said Karpa, Ph.D., R.Ph., assistant professor, department of pharmacology, Pennsylvania State University College of W A sampling of probiotic products Everidis Health Sciences is offering BioGaia Probiotic Drops. The oil suspension product is available in a drop form delivery system to allow easy administration to infants. The ingredient in BioGaia is Lactobacillus reuteri. American Lifeline is providing Florajen3 for restoring and maintaining gastrointestinal health. Ingredients include lactobacillus acidophilus, bifidobacterium bifidum Bb-12, and bifidobacterium longum. Biocodex markets Florastor and FlorastorKids. Both probiotics contain live yeast cells and are intended to promote and maintain intestinal health and normal bowel function. Both products are made of live freeze-dried yeast cells of the species Saccharomyces boulardii. Natren Inc. is rolling out Trenev Trio capsules. The delivery system utilizes sunflower oil and vitamin E, which have all oxygen and water removed to create a totally anaerobic environment, which the company claims is ideal for keeping the bacteria in a state of arrested growth until they are introduced into your system and are ready to act at peak performance. Amerifit Brands Inc. markets Culturelle, which contains lactobacillus GG (LGG). Nature’s Bounty is making available Probiotic Acidophilus Dietary Supplement Capsules. Sustenex is a probiotic from Ganeden Biotech. It contains GanedenBC30, a proprietary, patented strain of Bacillus coagulans designed to help promote immune and digestive fitness. Medicine and author of Bacteria for Breakfast: Probiotics for Good Health. Probiotics are live microorganisms or “friendly” bacteria that when consumed in adequate amounts may provide health benefits. Classified as dietary supplements, they can also be found in a variety of fermented products, such as yogurt. The field of probiotics is exploding, fueled by studies published in the United States as well as an increased awareness among patients. David Sullivan, president of American Lifeline Inc., commented, “Healthcare professionals are finally recognizing that the benefits of quality probiotics are outweighing the risks.” Noting that 20% to 25% of people who take an antibiotic will develop antibiotic-associated diarrhea, Karpa said, “Of those people who get diarrhea, a fraction will go on to develop Clostridium difficile diarrhea. It is estimated that three million Americans live with C. difficile diarrhea and they cannot get rid of it,” she said. Here’s where probiotics come in handy. Karpa said that clinical studies show that probiotics are not only helpful in reducing and maintaining remission of inflammatory bowel conditions, they are also beneficial in treating food allergies in children and recurrent vaginal infections. Karpa advises pharmacists who want to sell and counsel on probiotics to do the following: •Refrigerate probiotics in the pharmacy or they will lose 25% of their viable organisms every three to four months. •Know the number of bacteria guaranteed through the expiration date, not at the time of manufacture. The product should have a count of 10 to 20 billion per dose guaranteed through the expiration date. •Products that contain lactobacillus or bifido bacteria are recommended. •Avoid products with soil-based organisms (SBO) because some of the organisms contained in the SBO products are spore formers. “If they leave the intestinal tract and go somewhere else in the body, they can cause an infection that is nearly impossible to get rid of.” •Advise patients that they may experience short-lived gastrointestinal cramping/bloating. “This (reaction) is thought to be a die-off effect of the pathogens.” For more information on probiotics, visit www.us probiotics.org, www.isapp.net, and www.dannon probioticscenter.com. http://www.drugtopics.com http://www.usprobiotics.org http://www.usprobiotics.org http://www.isapp.net http://www.dannonprobioticscenter.com http://www.dannonprobioticscenter.com
Table of Contents Feed for the Digital Edition of Drug Topics - May 12, 2008 Drug Topics - May 12, 2008 Contents Latebreakers Letters R.Ph.s Say More Needs to be Done to Prevent Pediatric Drug Errors There's a New School of Thought on Use of Beta-Blockers for Hypertension Cover Story Guest Spot Letters Clinical Practice Special Report Professional Practice Broad Label for New Leukemia Therapy Looks Promising Treating Asthma During Pregnancy Safer than Not, Says New Guide In the Pipeline Clinical Q&A APhA Leader's Plan to Leave Office Takes Center Stage at its Conference Policies Passed at a Glance Giving a Talk to the Community? Check Out These Materials This Foundation has Funds to Spare JP at Large Cover Story: Employers and R.Ph.S: A Win-Win Combo FDA's Ilisa Bernstein Discusses Pharmacy Affairs Legal Q&A Manufacturers Unleash a Rash of Poison Ivy Treatments Are OTC Cold Remedies Safe for Kids? Probiotics are All the Rage: How You Can Capitalize on It CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns CVS Caremark's Mentoring Program Recruits and Retains R.Ph.s Antibiotic Resistance Among Community Pathogens Technology Update New Products Advertisers Index Classified Viewpoint Drug Topics - May 12, 2008 Drug Topics - May 12, 2008 - Drug Topics - May 12, 2008 (Page Cover1) Drug Topics - May 12, 2008 - Drug Topics - May 12, 2008 (Page Cover2) Drug Topics - May 12, 2008 - Drug Topics - May 12, 2008 (Page 1) Drug Topics - May 12, 2008 - Contents (Page 2) Drug Topics - May 12, 2008 - Contents (Page 3) Drug Topics - May 12, 2008 - Contents (Page 4) Drug Topics - May 12, 2008 - Contents (Page 4A) Drug Topics - May 12, 2008 - Contents (Page 4B) Drug Topics - May 12, 2008 - Contents (Page 5) Drug Topics - May 12, 2008 - Latebreakers (Page 6) Drug Topics - May 12, 2008 - Latebreakers (Page 7) Drug Topics - May 12, 2008 - Latebreakers (Page 8) Drug Topics - May 12, 2008 - Latebreakers (Page 9) Drug Topics - May 12, 2008 - Letters (Page 10) Drug Topics - May 12, 2008 - Letters (Page 11) Drug Topics - May 12, 2008 - R.Ph.s Say More Needs to be Done to Prevent Pediatric Drug Errors (Page 12) Drug Topics - May 12, 2008 - R.Ph.s Say More Needs to be Done to Prevent Pediatric Drug Errors (Page 13) Drug Topics - May 12, 2008 - There's a New School of Thought on Use of Beta-Blockers for Hypertension (Page 14) Drug Topics - May 12, 2008 - There's a New School of Thought on Use of Beta-Blockers for Hypertension (Page 15) Drug Topics - May 12, 2008 - There's a New School of Thought on Use of Beta-Blockers for Hypertension (Page 16) Drug Topics - May 12, 2008 - Cover Story (Page HSE1) Drug Topics - May 12, 2008 - Guest Spot (Page HSE2) Drug Topics - May 12, 2008 - Guest Spot (Page HSE3) Drug Topics - May 12, 2008 - Guest Spot (Page HSE4) Drug Topics - May 12, 2008 - Letters (Page HSE5) Drug Topics - May 12, 2008 - Clinical Practice (Page HSE6) Drug Topics - May 12, 2008 - Clinical Practice (Page HSE7) Drug Topics - May 12, 2008 - Clinical Practice (Page HSE8) Drug Topics - May 12, 2008 - Special Report (Page HSE9) Drug Topics - May 12, 2008 - Special Report (Page HSE10) Drug Topics - May 12, 2008 - Special Report (Page HSE11) Drug Topics - May 12, 2008 - Professional Practice (Page HSE12) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 17) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 18) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 19) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 20) Drug Topics - May 12, 2008 - Broad Label for New Leukemia Therapy Looks Promising (Page 21) Drug Topics - May 12, 2008 - Treating Asthma During Pregnancy Safer than Not, Says New Guide (Page 22) Drug Topics - May 12, 2008 - Treating Asthma During Pregnancy Safer than Not, Says New Guide (Page 23) Drug Topics - May 12, 2008 - In the Pipeline (Page 24) Drug Topics - May 12, 2008 - In the Pipeline (Page 24A) Drug Topics - May 12, 2008 - In the Pipeline (Page 24B) Drug Topics - May 12, 2008 - Clinical Q&A (Page 25) Drug Topics - May 12, 2008 - Clinical Q&A (Page 26) Drug Topics - May 12, 2008 - Clinical Q&A (Page 27) Drug Topics - May 12, 2008 - Clinical Q&A (Page 28) Drug Topics - May 12, 2008 - Clinical Q&A (Page 29) Drug Topics - May 12, 2008 - Clinical Q&A (Page 30) Drug Topics - May 12, 2008 - Clinical Q&A (Page 31) Drug Topics - May 12, 2008 - Clinical Q&A (Page 32) Drug Topics - May 12, 2008 - Clinical Q&A (Page 33) Drug Topics - May 12, 2008 - Policies Passed at a Glance (Page 34) Drug Topics - May 12, 2008 - Policies Passed at a Glance (Page 35) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 36) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 36A) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 36B) Drug Topics - May 12, 2008 - This Foundation has Funds to Spare (Page 37) Drug Topics - May 12, 2008 - JP at Large (Page 38) Drug Topics - May 12, 2008 - JP at Large (Page 39) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 40) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 41) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 42) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 43) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 44) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 45) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 46) Drug Topics - May 12, 2008 - Cover Story: Employers and R.Ph.S: A Win-Win Combo (Page 47) Drug Topics - May 12, 2008 - FDA's Ilisa Bernstein Discusses Pharmacy Affairs (Page 48) Drug Topics - May 12, 2008 - FDA's Ilisa Bernstein Discusses Pharmacy Affairs (Page 49) Drug Topics - May 12, 2008 - Legal Q&A (Page 50) Drug Topics - May 12, 2008 - Legal Q&A (Page 51) Drug Topics - May 12, 2008 - Legal Q&A (Page 52) Drug Topics - May 12, 2008 - Manufacturers Unleash a Rash of Poison Ivy Treatments (Page 53) Drug Topics - May 12, 2008 - Are OTC Cold Remedies Safe for Kids? (Page 54) Drug Topics - May 12, 2008 - Are OTC Cold Remedies Safe for Kids? (Page 55) Drug Topics - May 12, 2008 - Probiotics are All the Rage: How You Can Capitalize on It (Page 56) Drug Topics - May 12, 2008 - Probiotics are All the Rage: How You Can Capitalize on It (Page 57) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 58) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 59) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 60) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 61) Drug Topics - May 12, 2008 - CMS' Prices for Round One of DMEPOS Competitive Bidding Raising Concerns (Page 62) Drug Topics - May 12, 2008 - CVS Caremark's Mentoring Program Recruits and Retains R.Ph.s (Page 63) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 64) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 65) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 66) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 67) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 68) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 69) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 70) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 71) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 72) Drug Topics - May 12, 2008 - Antibiotic Resistance Among Community Pathogens (Page 73) Drug Topics - May 12, 2008 - Technology Update (Page 74) Drug Topics - May 12, 2008 - Technology Update (Page 75) Drug Topics - May 12, 2008 - Technology Update (Page 76) Drug Topics - May 12, 2008 - Advertisers Index (Page 77) Drug Topics - May 12, 2008 - Advertisers Index (Page 78) Drug Topics - May 12, 2008 - Classified (Page 79) Drug Topics - May 12, 2008 - Classified (Page 80) Drug Topics - May 12, 2008 - Classified (Page 81) Drug Topics - May 12, 2008 - Classified (Page 82) Drug Topics - May 12, 2008 - Classified (Page 83) Drug Topics - May 12, 2008 - Classified (Page 83A) Drug Topics - May 12, 2008 - Classified (Page 83B) Drug Topics - May 12, 2008 - Viewpoint (Page 84) Drug Topics - May 12, 2008 - Viewpoint (Page Cover3) Drug Topics - May 12, 2008 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.